II

Innovis Investments

North America, California, United States, Irvine

Description

Innovis Investments is a venture capital fund focused on investments in biotechnology, pharmaceuticals, and healthcare industries.

Investor Profile

Innovis Investments has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, Australia.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.

Stage Focus

  • Series D (75%)
  • Series Unknown (25%)

Country Focus

  • United States (75%)
  • Australia (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Manufacturing
  • Medical
  • Therapeutics
  • Health Diagnostics
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Innovis Investments frequently co-invest with?

Eli Lilly & Company Foundation
North America, Indiana, United States, Indianapolis
Co-Investments: 1
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Alexandria Real Estate Equities
North America, California, United States, Pasadena
Co-Investments: 1
Nextech Venture
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Mitsubishi UFJ
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
CIDC Consultants
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Arcus Ventures
North America, New York, United States, New York
Co-Investments: 1
Red Abbey Venture Partners
North America, Maryland, United States, Baltimore
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2

What are some of recent deals done by Innovis Investments?

MacroGenics

Rockville, Maryland, United States

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

BiotechnologyHealth CareManufacturing
Series DOct 23, 2008
Amount Raised: $25,000,000
Xenome

Brisbane, Queensland, Australia

Xenome, a biopharmaceutical company, developed a therapeutic product for the management of moderate to severe pain.

BiopharmaBiotechnologyMedicalTherapeutics
Series UnknownNov 27, 2007
Amount Raised: $10,000,000
Agensys

Santa Monica, California, United States

Agensys offers products to treat various tumors as well as prostate, pancreatic and bladder cancers.

BiotechnologyHealth DiagnosticsPharmaceutical
Series DJul 12, 2007
Amount Raised: $41,300,000
TargeGen

San Diego, California, United States

TargeGen, Inc., a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target.

BiopharmaBiotechnologyHealth Care
Series DJul 12, 2007
Amount Raised: $40,000,000